Abstract: The interactions of Salmonella enterica subspecies I serotype Abortusovis (S. Abortusovis) with ovine afferent lymph dendritic cells (ALDCs) were investigated for their ability to deliver Maedi visna virus (MVV) GAG p25 antigens to ALDCs purified from afferent lymph. Salmonellae were found to enter ALDC populations by a process of cell invasion, as confirmed by electron and confocal microscopy. This led to phenotypical changes in ALDC populations, as defined by CD1b and CD14 expression. No differences in the clearance kinetics of intracellular aroA-negative Salmonella from CD1b ؉ CD14 lo and CD1b ؉ CD14 -ALDC populations were noted over 72 h. ALDCs were also shown to present MVV GAG p25 expressed by aroA-negative S. Abortusovis to CD4 ؉ T lymphocytes. Thus, the poor immune responses that Salmonella vaccines elicited in large animal models compared with mice are neither a result of an inability of Salmonella to infect large animal DCs nor an inability of these DCs to present delivered antigens. However, the low efficiency of infection of ALDC compared with macrophages or monocyte-derived DCs may account for the poor immune responses induced in large animal models.
INTRODUCTION
The interactions of professional APCs with invading pathogens are of great interest, considering the essential role these cells play in initiating and regulating immune responses [1, 2] . In particular, dendritic cells (DCs) situated at the primary interface between the body and the environment, i.e., skin and mucosal surfaces, are exposed to all manner of antigenic insults. As the only APC capable of stimulating naive T cells, DCs represent important targets for vaccination strategies. In this respect, future vaccine design is likely to take into account the ability of a vaccine to be presented by DCs.
As a result of the increased immune responses they elicit, live vaccines are generally favored over their killed or subunit counterparts [3] . Unfortunately, for various reasons, not all pathogens can be attenuated. Thus, the use of successfully attenuated pathogens as live delivery vehicles for recombinant antigens has been studied [4, 5] . In particular, bacteria, which can have an intracellular existence in APCs, e.g., Salmonella or Listeria monocytogenes, are particularly attractive as vehicles to deliver antigen to the appropriate inductive cells of the immune system, stimulating CD4 and CD8 T cell responses. Unfortunately, the success obtained in murine models has yet to be fully transferred to humans and other larger animal models.
There are a limited number of studies suggesting that Salmonellae are taken up by DCs [6 -10] . In these studies, DCs derived in vitro or a DC-like cell line were used. Although these do show morphological and phenotypical features similar to DCs derived ex vivo, the full extent to which DCs generated with nonphysiological quantities of cytokines model those in vivo is still uncertain. More recently, investigations into the interaction between murine DCs and Salmonella typhimurium have been carried out in vivo, providing useful information about the involvement of DCs in the priming of naive T cells to Salmonella in vivo [11, 12] . Only one study in an in vivo large animal model is available [13] . With many clinical applications failing to make the transition from rodent to humans, there is a place for these studies, which offer experimental opportunities not available in in vitro murine systems [14] .
Here, we investigate the ability of Salmonella enterica subspecies I serotype Abortusovis (S. Abortusovis), a sheep-specific strain of Salmonella, to infect ex vivo afferent lymph DCs (ALDCs). The pseudoafferent lymphatic cannulation model offers a source of physiologically generated DCs and can be considered to be representative of the DC populations that are migrating from the periphery, having encountered antigen and/or pathogens. Work with more physiologically relevant sources of DCs [15, 16] is essential if attenuated Salmonella delivery vehicles are to be used successfully for clinical applications.
Bacterial strains
S. Abortusovis SS44wt has been described previously [17] . SU304 is an aroA deletion mutant and was a gift from Dr. Sergio Uzzau (Department of Biomedical Science, University of Sassari, Italy) [18] . SU304 was grown in Luria Bertani (LB) broth supplemented with para-aminobenzoic acid at 10 g/ml. SS44wt-GFP was created by transforming SS44wt with GFP cloned downstream of a TAC promoter in the plasmid pKEN [19] . SU304225, expressing the EV1 strain of the Maedi visna virus (MVV) p25 gag gene [20] , was generated by transforming p25 cDNA cloned into the vector pTECH2 (Medeva, London, UK) [21] into SU304. SU3042 was SU304 transformed with the empty pTECH2 vector. pTECH2 uses the nirB promoter to express tetC fusion proteins. This allows expression of recombinant antigen in situations of low oxygen tension, i.e., within cells. Plasmid was stable within cells for up to 24 h when ampicillin selection was removed.
Flow cytometry and antibodies
Cell-surface phenotype was analyzed by flow cytometry. mAb were against ovine cell surface antigens or were mAb known to cross-react with their ovine homologue. Briefly, cells were washed in PBS containing 0.1% BSA and 0.01% sodium azide (FACS wash buffer) and incubated with 1-2 g/ml purified primary antibody for 40 min on ice. After two washes in FACS wash buffer, cells were incubated on ice in isotype-specific, Tri-color-conjugated sheep anti-mouse antibodies and strepavidin-PE at optimal dilutions for 20 min. Isotype control antibodies were used to indicate background staining and autofluorescence and used to set gates and quadrants for analysis. mAb used were VPM65 for CD14 [22] and biotinylated CC20 for CD1b [23] .
Production of macrophages and DCs from PBMCs
Generation of macrophages from ovine PBMCs was carried out as described previously [24] . Ovine in vitro-derived DCs were also generated as described previously [25] .
Pseudoafferent lymphatic cannulations
Sheep had their prefemoral or popliteal lymph nodes removed under general anesthesia. A minimum of 8 weeks later, the pseudoafferent lymphatic vessel, resulting from re-anastomosis of afferent and efferent vessels, was cannulated as described previously [26] . Lymph was collected in sterile 250 ml capacity polypropylene bottles containing 250 U sodium heparin. Bottles were changed two to three times daily, as and when necessary Enrichment and isolation of afferent lymph for DCs by density gradient, MACS, and FACsort Cells from afferent lymph were washed in calcium and magnesium-free HBSS with 2% FCS, 0.2 mM EDTA, at 4°C. These were then resuspended in ice-cold RPMI/10% FCS, overlaid onto a discontinuous gradient of 11.5% v/v Optiprep (Nyegaard Diagnostics, Oslo, Norway), diluted in the same medium, and centrifuged at 800 g for 20 min at 4°C. Cells at the interface were washed twice in RPMI/2% FCS before use as an enriched source of ALDCs. These cells were stained as above for CD1b (with CC20 biotin for MACS) and/or CD14 expression and used for MACS or FACsorting. For MACS, cells were stained with streptavidin microbeads, and positively stained cells were selected on a magnetized column. Cells were kept on ice for FACsorting on a Becton Dickinson FACStar.
An Optiprep density gradient of 11.5% was found to enrich for large cells at levels comparable with that of a 14.5% Metrizamide gradient [26, 27] , i.e., up to 80% (data not shown) with a contaminating population of small cells (lymphocytes) present. Named as Optiprep gradient-enriched cells, the morphology and phenotype of these large cells were consistent with ovine ALDCs, as defined previously by others when gates were set for a DC analysis region, i.e., cells of high forward-and side-scatter [27] .
Bacterial internalization by cells quantified using bacteria expressing GFP Density gradient-enriched ALDCs, monocyte-derived DCs, or macrophages were infected with bacteria at a multiplicity of infection (MOI) of 10 for 1 h. Cells were then washed three times with PBS and stained for flow cytometry as usual. As controls for determining the number of bacteria associated with but not internalized by DCs or macrophages, cells were preincubated with Cytochalasin D at a final concentration of 10 g/ml for 60 min at 37°C prior to infection. Cytochalasin D was present throughout the duration of the infection at 10 g/ml.
Transmission electron microscopy (TEM)
Samples containing 5 ϫ 10 6 cells (infected as above) were washed in PBS, pelleted, and fixed in 2.5% glutaraldehyde. After washing with 0.13 M phosphate buffer, pH 7.4, fixed cells were postfixed in 1% (w/v) osmium tetroxide/ 0.13 M phosphate buffer at 4°C before dehydrating in a graded series of ethanol. The cells were then incubated in propylene oxide and embedded in 1:1 propylene oxide/epoxy resin mix followed by a 100% epoxy resin mix. Samples were polymerized (cured) by baking at 60°C until the resin hardened.
Scanning EM (SEM)
Washed samples were pipetted as a cell suspension onto an Anodisc and fixed in 2.5% (v/v) glutaraldehyde. After coating in 1% (w/v) osmium tetroxide/0.13 M phosphate buffer at 4°C for 1 h, samples were washed and dehydrated through an acetone gradient. Finally, samples were dried with the critical point drying agent Hexamethyldisilazone mounted on an aluminium stub and coated with gold.
Confocal microscopy
Confocal microscopy was performed on a Leica TCS-NT-UV confocal laserscanning microscope. Cells were cytospun onto precleaned microscope slides and then stained with phalloidin-conjugated rhodamine (0.2 mg/ml) and mounted in a 4Ј-diamidino-2-phenylindole microscopy slide mountant.
Salmonella survival in phagocytic cells (gentamicin survival assay)
Cells were infected with Salmonella at a MOI of 10 for 1 h at 37°C before washing three times with PBS and incubating at 37°C with DMEM (Cat. No. 19965, Invitrogen), supplemented with 10% FCS. Initially, for the first hour, gentamicin was added to a final concentration of 50 g/ml, after which, it was lowered to 10 g/ml. At different time intervals, the DCs were washed with PBS and lysed with 0.1% Triton X-100, equilibrated at 37°C. The number of viable intracellular bacteria was determined by plating serial dilutions onto LB agar with the appropriate supplements and counting colonies that grew overnight.
DC presentation of recombinant MVV p25 antigen expressed by Salmonella
ALDCs and in vitro monocyte-derived DCs from sheep primed to MVV p25 were infected with SU304225 at a MOI of 50 for 4 h (cells were viable after this time, as assessed by trypan blue staining). Extracellular bacteria were removed by washing, and cells were cocultured with autologous-purified CD4 lymphocytes (1ϫ10 5 cells/well of a 96-well plate) using 2 ϫ 10 5 in vitro-derived DCs or 1 ϫ 10 5 ALDCs in RPMI/10% FCS containing 10 g/ml gentamicin. Cells were cultured for 5 days at 37°C with 1 Ci [3H]-thymidine, added for the last 16 h, harvested, and then counted by liquid scintillation. Wells were set up in triplicate, and proliferation was compared with T cells stimulated by APCs infected with SU3042.
CD4 T cell lines specific for MVV p25 were derived from sheep immunized with recombinant p25. PBMCs were stimulated with p25 (at an optimal concentration, 25-50 g/ml for 5-6 days) and then recombinant human IL-2 (20 U/ml for 5-6 days). The stimulation was repeated once before cells were stored in liquid nitrogen.
RESULTS

Surface molecule expression on ex vivo ALDC prior to and following encounter with Salmonella
Murine in vitro-derived bone marrow DCs and/or DC-like cell lines have previously demonstrated the ability of Salmonella to invade these cells successfully. To assess how ex vivo DC populations from afferent lymph interact with S. Abortusovis, flow cytometry was performed on Optiprep gradient-enriched cells Ϯ Cytochalasin D (to differentiate surface adherent and internalized bacteria), incubated with S. Abortusovis, expressing GFP, SS44wt-GFP. Setting markers so that less than 1% of cells was associated with SS44wt-GFP in the presence of Cytochalasin D, large and small cell populations were analyzed separately (Fig. 1, A-C) . Intracellular SS44wt-GFP could not be detected in the small cell (lymphocyte) population (Fig. 1B) . The large cell population (Fig. 1C) shows high autofluorescence, and the marker set in the presence of Cytochalasin D reflects this (less than 1% positive cells within the gate); however, these cells may also represent cells with bound extracellular bacteria. However, in the absence of Cytochalasin D, SS44wt-GFP was found in 1-3% of the large cell population, leading to the identity of the large cell population containing SS44wt-GFP to be investigated further by phenotypical analysis.
Previously, double-staining of density gradient-enriched large cells for CD1b and CD14 has revealed four populations of cells: CD1b -CD14 -; CD1b hi CD14 lo ; CD1b lo CD14 -; and occasionally, singly CD14 hi cells [27] . The first three of these cell populations are considered to be ALDCs, and the phenotype of the last cell population is more typical of contaminating macrophages. Although this experiment was repeated several times with cells obtained from two different sheep, CD1b expression was weak here compared with other studies, and so, CD1b hi and CD1b lo DC populations were not identified. ALDCs were seen to be CD1b ϩ and CD1b -. This weak expression of CD1b with some sheep has been observed previously with ALDCs (unpublished observation). Using these criteria, two populations of DCs based on CD1b and CD14 expression were found to contain Salmonella: CD1b ϩ CD14 hi and CD1b ϩ CD14 lo (Fig. 1E) , and large cell phenotypes that did not contain Salmonella were CD1b ϩ CD14 lo or CD1b -CD14 -phenotype (Fig. 1D) . However, as studies with human in vitroderived DCs have demonstrated the accumulation of CD1b in lysosomal MHC class II compartments [28] , comparisons of ALDC CD1b and CD14 expression before and after infection with Salmonella were made. As shown in Figure 1G , the level of expression as well as the number of large cells expressing CD1b were observed to increase to 83.6% compared with 33.4% in uninfected cells (Fig. 1F) . A smaller number of these CD1b cells were also observed to have an increase in CD14 expression. It is likely that these are DCs that have upregulated their CD14 expression, as first, ovine macrophages do not express CD1b [29] , and second, CD1b -CD14 hi macrophages were not observed prior to incubation with Salmonella.
It is interesting that the actual number of cells with increased CD1b expression exceeded the number of DCs containing SS44wt-GFP, as assessed by flow cytometry. Extending the infection time to 4 h and/or increasing the MOI to 50 cfu/cell did not cause further increases in expression of CD1b or CD14 (data not shown).
The proportion of ovine ALDCs containing intracellular Salmonella postinfection was two-to threefold lower than that seen with murine in vitro-derived DCs when incubated with Salmonella at an identical MOI. As most Salmonella-DC studies have used in vitro-derived DCs, uptake of SS44wt-GFP by ALDCs was also compared with uptake by in vitro ovine monocyte-derived DCs. These were consistently found to have intracellular SS44wt-GFP at levels that were at least twofold higher when compared with ex vivo ovine ALDCs (Fig. 2, A  and C, nϭ3, PϽ0 .05). The proportion of cells containing SS44wt-GFP was also five-to sixfold lower in ALDCs when compared with those of ovine monocyte-derived macrophages (Fig. 2, A and B, nϭ3, PϽ0 .05). Repeating the above experiments with a GFP-expressing, noninvasive Escherichia coli showed no uptake of the bacteria by ALDCs and greatly reduced levels of bacterial uptake by in vitro-derived macrophages and DCs (data not shown).
Entry and intracellular localization of S. Abortusovis in ALDCs
The previous experiments suggest that ALDCs were poorly phagocytic. As flow cytometry was only able to assess the relative uptake of Salmonella, we wanted to exclude the possibility that perhaps intracellular Salmonella resided within all ALDCs and that only DCs containing greater than a particular threshold number of Salmonella were detectable. To address these uncertainties as well as to provide information about the intracellular location of Salmonella and the morphology of ALDCs following infection, Optiprep gradient-enriched cells were incubated with S. Abortusovis SS44wt before fixing and processing for EM.
Distinguishing ALDCs from lymphocytes and macrophages by size and morphology, TEM revealed that few of the infected DCs contained intracellular S. Abortusovis. Of the 50 DCs counted, only three contained Salmonella, consistent with the low percentage of DCs found to contain Salmonella by flow cytometry. Generally, three to four Salmonella were found in each of the infected DCs (Fig. 3A) . These intracellular bacteria were not observed to escape into the cytosol and inhabited vacuoles that were surrounded by single membranes (Fig. 3B) . Occasionally, more than one bacterium was observed within these vacuoles (Fig. 3C) ; otherwise, each vacuole was inhabited by a single bacterium. As expected with the intracellular survival abilities of Salmonella, fusion of lysosomal vesicles to vacuoles containing S. Abortusovis SS44wt was not observed, nor were vacuoles containing bacteria encapsulated by multilaminar structures. The latter has been described for S. typhimurium phoP mutants in the DC line CB1 and is reminiscent of MHC class II compartments [8] .
The small proportion of ALDCs capable of internalizing Salmonella could have been as a result of cellular phagocytosis or by Salmonella invasion of the cell. The latter is reminiscent of macropinocytosis, whereby Salmonella induces cytoskeletal modifications and ruffling of the cell membrane to mediate its uptake. This is accomplished by localized accumulation of actin around the invading bacteria. Poor phagocytic activity necessitating active invasion of ALDCs would explain the lack of intracellular, noninvasive E. coli above. However, the TEM studies (Fig. 3) were unable to make a conclusive distinction. Therefore, SEM was used to observe ALDCs after incubation with S. Abortusovis SS44wt. Although no extracellular S. Abortusovis was observed adhered to ovine ALDCs, heavy cell-surface modifications and cell-membrane extensions resembling membrane ruffling were present in the presence of S. Abortusovis (Fig. 4, A and B) . Neither of these appeared on cells not incubated with S. Abortusovis.
Further evidence that Salmonella enters ovine ALDC by invasion was obtained by confocal microscopy to show actin polymerization. For EM studies, Salmonella and ALDC were incubated for 1 h; this may be long enough to allow all adherent bacteria to enter the cell. Therefore, a shorter incubation time (10 min) was used for confocal microscopy. Indeed, Salmonella invasion of epithelial cells is known to occur within minutes of bacterium-cell surface contact [30] . CD1b ϩ ALDCs selected by MACS were incubated with SS44wt-GFP and then counterstained for polymerized actin with rhodamine-conjugated phalloidin. Actin polymerization was found directly beneath the surface of the cell, colocalizing with the adherence of SS44wt-GFP to the cell (Fig. 5) . The lack of uptake of noninvasive E. coli (above), the presence of membrane ruffles (above), and the actin polymerization all suggest that Salmonella residing within ALDCs had entered by invasion.
Survival and growth of S. Abortusovis in ALDCs
Entry of Salmonella into phagocytic cells is normally accompanied by Salmonella growth and replication, despite the hostile environment that is created within such cells by reactive oxygen and nitrogen species and degradative enzymes. To determine whether ALDCs could serve as a host for intracellular Salmonella growth, CD1b ϩ CD14 lo and CD1b ϩ CD14 -populations FACsorted from afferent lymph were cultured in the presence of wild-type S. Abortusovis SS44wt and an aroA-S. Abortusovis mutant, SU304. Extracellular bacteria were eliminated, and viable intracellular bacteria were quantified by a gentamicin survival assay. At least 85% of cells were found to be viable at 72 h postinfection (as assessed by trypan blue exclusion). As seen in Figure 6 , although cells from different sheep showed slightly different abilities to control and clear invasive Salmonella, the intracellular growth and survival trends for the wild-type and aroA-strains were similar between the two sheep. SS44wt survived but did not replicate well (1 log increase in B1693 CD1b ϩ CD14 -cells, Fig. 6D ), whereas SU304 showed reduced intracellular bacterial numbers over the time course of the experiment (fully cleared by B1136 cells but only 2-3 log reduction by B1693 cells within 72 h) in CD1b ϩ CD14 lo and CD1b ϩ CD14 -ALDCs. The reduced ability of ALDCs from sheep B1693 to control intracellular Salmonella growth may be a result of natural resistance phenotype compared with sheep B1136 (sheep are not inbred, and so, e.g., Nramp status may vary).
Salmonella delivery of recombinant antigen to DCs for presentation to CD4 lymphocytes
It has been hypothesized that the effectiveness of Salmonella vaccines as delivery vehicles must depend on their ability to interact with and infect DCs. With the low levels of Salmonella uptake by ALDCs, we were therefore interested to know whether such low levels affected the ability of ALDCs to present antigen for an antigen-specific response. Consequently, we isolated/generated ex vivo afferent lymph and in vitro monocyte-derived DCs from sheep primed to MVV recombinant gag p25. These were infected in vitro with an attenuated aroA-S. Abortusovis mutant expressing MVV gag p25 (SU304225) and subsequently cultured with autologous CD4 antigen-specific p25 T cells. The proliferation of lymphocytes was used as a read-out for antigen presentation. DCs infected for 1 h at MOIs of 10 and 20 did not induce the proliferation of CD4 antigen-specific p25 T cell lines (data not shown). Therefore, cells were infected for an increased length of time (4 h) at a higher MOI-50. Figure 7 demonstrates that under these conditions, in vitro monocyte-derived DCs and ex vivo ALDCs were capable of presenting Salmonella-expressed MVV GAG p25 antigen to CD4 antigen-specific p25 T cell lines.
DISCUSSION
To determine whether Salmonella can infect and survive in physiological populations of DCs, we have carried out investigations into the interactions between ovine ALDCs and the sheep-specific strain of S. Abortusovis. To our knowledge, this is the first large animal investigation of Salmonella DC interaction in vitro to use DCs from a physiological source.
Despite the ability of Salmonella to be internalized by ovine ALDCs, bacterial uptake was less than that seen with ovine monocyte-derived macrophages. With TEM studies confirming the low levels of intracellular S. Abortusovis residing within ALDCs, the internalization and uptake of bacteria by ovine ALDCs were less efficient than that of macrophages. Similar findings have been described when comparing the relative uptake of E. coli by bone marrow-derived mouse DCs to murine peritoneal macrophages [31] . A likely explanation is the lower levels of phagocytosis found in maturing ALDC populations [32] , meaning that uptake is reliant on invasion alone. Indeed, our in vitro-derived DC data along with preliminary data indicating a lack of noninvasive E. coli uptake by ALDCs would suggest that uptake of Salmonella by afferent lymph cells is a result of invasion and not phagocytosis. The cell-surface modifications seen with SEM and actin polymerization observed by confocal microscopy support this, which may also explain the low levels of bacteria associated with ALDCs draining a mucosal site of infection with S. Abortusovis [13] . This study showed that phagocytic cells, granulocytes and migratory monocytes, had higher levels of cell-associated bacteria than CD1b ϩ DCs; indeed, there were ϳ3.5-fold more Salmonellapositive monocytes than DCs.
Unlike humans and sheep, mice do not express a homologue of CD1b. Therefore, the changes in ALDC CD1b expression after incubation with S. Abortusovis were of particular interest. The overall percentage and actual number of CD1b expressing large cells increased by ϳ20%; this was at the expense of the CD1b -cell population. As the role of CD1b is the presentation of lipid antigens [33] [34] [35] , it is probable that these ovine ex vivo DCs up-regulate CD1b in response to a maturation stimulus. Increased CD1 expression on ovine ALDC is also seen in vivo after antigenic challenge [26] .
The inability of S. Abortusovis to infect lymphocytes ( Fig.  1 and ref. [13] ) suggested that in addition to intestinal mucosa in sheep [36] , macrophages (as shown in this study), and afferent lymph monocytes [13] , S. Abortusovis is able to infect ovine ALDCs selectively in vitro (this study) and in vivo [13] .
Salmonella containing deletions in the aro genes are impaired in their ability to reproduce [37] . Such Salmonella produce a self-limiting infection that is of long enough duration to deliver heterologous antigens they may be engineered to carry into APCs. FACsorting ovine ALDCs into CD1b ϩ CD14 lo and CD1b ϩ CD14 -cell populations did not reveal an obvious difference in the kinetics of S. Abortusovis survival between the two DC populations, in that SS44wt survived, and SU304 was cleared in both. A similar study that FACsorted CD11c ϩ DCs from fetal liver tyrosine kinase 3 ligand-treated mice into CD8a ϩ and CD8a -populations also failed to show any difference in intracellular bacterial growth and survival once these two DC populations were infected with wild-type Salmonella Dublin [38] . Salmonellae residing within DC vacuoles do not require macrophage virulence factors for intracellular DC survival, and the vacuoles themselves do not have lysosomal markers, unlike macrophage vacuoles in which Salmonella reside [8, 39] . Wild-type S. Abortusovis was able to persist in ovine ALDCs, whereas an aroA-S. Abortusovis mutant, SU304, is cleared rapidly. In contrast, wild-type S. typhimurium has been shown to be cleared slowly from human monocyte-derived DC [9] .
Despite the rapid clearance of SU304 from ALDCs following infection, SU304225, which expressed MVV p25 from the nirB promoter as a tetC fusion protein, presented p25 to specific CD4 T cell lines, albeit at a high MOI. Although murine studies have been carried out by others [6, 11] , this is the first study to demonstrate that ex vivo maturing ALDCs infected by an attenuated Salmonella carrying recombinant antigens can stimulate a CD4 antigenspecific T cell response. The high MOIs required for the ALDCs to present antigen to CD4 T cell lines were unexpected, considering the efficiency with which DCs present antigen. However, ALDCs are considered to be a maturing population, which may mean that their ability to process new antigen from invading Salmonellae is decreased. In contrast, Ruedl and colleagues [40] have described Langerhans cells given a maturation stimulus in vivo, continuing to have the ability to take up and process native protein (which was present throughout the T cell proliferation assays). Recent data from mice have also shown that virulent S. typhimurium reduces antigen presentation on MHC classes I and II molecules by interfering with phagosome lysosome fusion using Salmonella pathogenicity island 2-coded effector proteins [41] [42] [43] [44] . The need for a high MOI to produce efficient antigen presentation may reflect the presence of similar immune evasion mechanisms in S. Abortusovis.
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